Figure 51.
(a) Chemical structure of β-glucuronic linker and corresponding release mechanism. Drugs contains primary (doxorubicin) or secondary amine (MMAE, MMAF) (b) Chemical structure and release mechanism of DMED-containing β-Glucuronidase cleavable linker. Drug structures are omitted for clarity.
